Sanofi: Perbedaan antara revisi
Tampilan
Konten dihapus Konten ditambahkan
k RaymondSutanto memindahkan halaman Sanofi-Aventis ke Sanofi: berganti nama |
Tidak ada ringkasan suntingan |
||
Baris 1: | Baris 1: | ||
{{Infobox company |
|||
{{Infobox_Company | |
|||
| name = Sanofi S.A. |
|||
| logo = [[File:Sanofi.svg|150px]] |
|||
| type = [[Société Anonyme]] |
|||
company_type = Publik ([[Euronext]] [http://www.euronext.com/trader/summarizedmarket/0,5372,1732_6834,00.html?selectedMep=1&idInstrument=20812&isinCode=FR0000120578 SAN], [[New York Stock Exchange|NYSE]], [[London Stock Exchange|LSE]] dan [[Frankfurt Stock Exchange|FWB]])| |
|||
| traded_as = {{Euronext|SAN}}, {{NYSE|SNY}}, {{LSE|0I42}}, {{FWB|SNW}} |
|||
company_slogan = Because health matters. ([[Bahasa Perancis|Perancis]]: ''L'essentiel c'est la santé.'')| |
|||
foundation = |
| foundation = 20 Agustus 2004 (akuisisi) sebagai Sanofi Aventis<br />6 May 2011 sebagai Sanofi |
||
location = [[Paris]], [[ |
| location = 54, rue La Boétie, [[8th arrondissement of Paris|8th arrondissement]], [[Paris]], [[France]] |
||
key_people = [[Jean-François Dehecq]] |
| key_people = [[Chris Viehbacher]] <small>([[chief executive officer|CEO]])</small>, [[Serge Weinberg]] <small>([[Chairman]])</small>, [[Jean-François Dehecq]] <small>([[Original Founder]])</small> |
||
industry = |
| industry = [[Industri obat-obatan]] |
||
| products = [[Prescription drug|Prescription]] and [[over-the-counter drug]]s for [[trombosis]], [[cardiovascular disease]], [[diabetes]], kelainan [[sistem saraf pusat]], [[onkologi]] and [[internal medicine]], [[vaksin]] ([[#Products|list...]]) |
|||
num_employees = 96,439 (2004) | |
|||
| revenue = [[Euro|€]]32.95 milyar (2013)<ref name="AR2013">{{cite web |url=http://en.sanofi.com/Images/35795_20-F_2013.pdf |title=Annual Report 2013 |accessdate=13 April 2014 |publisher=Sanofi-Aventis}}</ref> |
|||
products = [[Cardiovascular]], [[central nervous system]], [[oncology]], dan [[internal medicine]] formulations.{{br}}Flagship products:{{br}}[[Fexofenadine|Allegra®]] (allergy){{br}}[[Enoxaparin|Lovenox®]] (deep vein thrombosis){{br}}[[Clopidogrel|Plavix®]] (thrombosis){{br}}[[Irbesartan|Avapro®]] (hypertension){{br}}[[Zolpidem|Ambien®]] (insomnia){{br}}[[Oxaliplatin|Eloxatin®]] (chemotherapy) {{br}} [[Telithromycin|Ketek®]] ([[ketolide]] [[antibiotic]])| |
|||
| operating_income = €5.11 milyar (2013)<ref name="AR2013" /> |
|||
revenue = [[Berkas:green up.png]]27.311 miliar [[euro]]s ([[2005]]){{br}} ($34.013 billion [[Dolar Amerika Serikat|USD]])| |
|||
| net_income = €3.72 milyar (2013)<ref name="AR2013" /> |
|||
⚫ | |||
| assets = €96.07 milyar (2013)<ref name="AR2013" /> |
|||
| equity = €56.89 milyar (2013)<ref name="AR2013" /> |
|||
| num_employees = 112.128 (2013)<ref name="AR2013" /> |
|||
| subsid = [[Sanofi Pasteur]]<br>[[Genzyme]]<br>[[Shantha Biotechnics]]<br>[[Chattem]]<br>[[Zentiva]]<br>[[Medley]]<br>Nichi-Iko<br>Merial |
|||
⚫ | |||
| intl = yes |
|||
}} |
}} |
||
'''Sanofi |
'''Sanofi S.A.''' ({{Euronext|SAN}}, {{NYSE|SNY}}), merupakan satu dari lima perusahaan [[farmasi]] terbesar di dunia, setelah [[Pfizer]], [[Bristol-Myers]], [[Squibb]], [[Novarits]], dan [[GlaxoSmithKline]]. Bermarkas di [[Paris]]. Perusahaan ini menghasilkan berbagai macam farmasi. Didirikan pada tahun [[2004]] setelah [[Sanofi-Synthélabo]] gabung dengan [[Aventis]]. |
||
== Lihat pula == |
== Lihat pula == |
||
Baris 24: | Baris 30: | ||
* [http://www.sanofipasteur.com sanofi pasteur - The vaccines business of sanofi-aventis Group] |
* [http://www.sanofipasteur.com sanofi pasteur - The vaccines business of sanofi-aventis Group] |
||
{{Euro Stoxx 50 Companies}} |
|||
{{perusahaan-stub}} |
{{perusahaan-stub}} |
||
[[Kategori:Perusahaan Perancis]] |
[[Kategori:Perusahaan Perancis]] |
||
[[Kategori:Perusahaan farmasi]] |
[[Kategori:Perusahaan farmasi]] |
||
[[Kategori:Perusahaan yang didirikan tahun 2004]] |
Revisi per 17 Agustus 2014 07.18
Berkas:Sanofi.svg | |
Société Anonyme | |
Kode emiten | Euronext: SAN, NYSE: SNY, LSE: 0I42, FWB: SNW |
Industri | Industri obat-obatan |
Didirikan | 20 Agustus 2004 (akuisisi) sebagai Sanofi Aventis 6 May 2011 sebagai Sanofi |
Kantor pusat | 54, rue La Boétie, 8th arrondissement, Paris, France |
Tokoh kunci | Chris Viehbacher (CEO), Serge Weinberg (Chairman), Jean-François Dehecq (Original Founder) |
Produk | Prescription and over-the-counter drugs for trombosis, cardiovascular disease, diabetes, kelainan sistem saraf pusat, onkologi and internal medicine, vaksin (list...) |
Pendapatan | €32.95 milyar (2013)[1] |
€5.11 milyar (2013)[1] | |
€3.72 milyar (2013)[1] | |
Total aset | €96.07 milyar (2013)[1] |
Total ekuitas | €56.89 milyar (2013)[1] |
Karyawan | 112.128 (2013)[1] |
Anak usaha | Sanofi Pasteur Genzyme Shantha Biotechnics Chattem Zentiva Medley Nichi-Iko Merial |
Situs web | www |
Sanofi S.A. (Euronext: SAN, NYSE: SNY), merupakan satu dari lima perusahaan farmasi terbesar di dunia, setelah Pfizer, Bristol-Myers, Squibb, Novarits, dan GlaxoSmithKline. Bermarkas di Paris. Perusahaan ini menghasilkan berbagai macam farmasi. Didirikan pada tahun 2004 setelah Sanofi-Synthélabo gabung dengan Aventis.